Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-10-24 00:00:00 ET · period of report 2023-10-24 · accession 0001610717-23-000314 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-24 | 2023-10-24 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.49 | +35.0K | 384.3K | +10% | +$17.1K |
| D | 2023-10-24 | 2023-10-24 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | M - OptEx | $0.00 | -35.0K | 67.4K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-24 | M | A | 35,000 | $0.49 | 384,332 | D | — | — | (F1) Includes 174,000 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-10-24 | M | D | 35,000 | $0.00 | 67,446 | D | $0.49 · 2020-12-01 to 2027-03-20 | 35,000 Common Stock |